Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 5Phase NA 3Phase 4 1Phase 1/2 1

Status

Completed 35Terminated 6Recruiting 6Unknown 5Active not recruiting 2

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3Dermatologic 1CNS 1

Conditions

Hodgkin Disease 3Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Lymphoma 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Dacarbazine × Clear all
NCT00736320 2020-11-04

HD16

University of Cologne

Phase 3 Unknown
1,150 enrolled
Lymphoid

Hodgkin Disease

NCT00041210 2013-09-20

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
850 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00410631 2013-08-07

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
642 enrolled
CNS

Neuroblastoma

NCT00816959 2011-07-20

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

American Scitech International

Phase 3 Unknown
1,200 enrolled
Lymphoid

Hodgkin Disease

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown
360 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡